Erratum to: “Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties” by Duncan et al. (Biological Psychiatry (2017) 82(5) (361–369) (S0006322317313689) (10.1016/j.biopsych.2017.03.011);Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties

Biological Psychiatry

Volumn 82, Issue 5, 2017, Pages 361-369

  Duncan, Wallace C ^a   Slonena, Elizabeth ^a   Hejazi, Nadia S ^a   Brutsche, Nancy ^a   Yu, Kevin C ^a   Park, Lawrence ^a   Ballard, Elizabeth D ^a   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Clock genes; Neuroplasticity; Sleep deprivation; Slow wave sleep; Wrist activity

Indexed keywords

KETAMINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; PRIORITY JOURNAL; ACTIMETRY; AFFECT; DRUG EFFECT; DRUG RESISTANCE; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP; TIME FACTOR; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; YOUNG ADULT;

ACTIGRAPHY; ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG RESISTANCE; FEMALE; HUMANS; KETAMINE; MALE; MIDDLE AGED; MOTOR ACTIVITY; SLEEP; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85018179934     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2017.07.004     Document Type: Erratum

References (68)

1. Bellet, M.M., Vawter, M.P., Bunney, B.G., Bunney, W.E., Sassone-Corsi, P., Ketamine influences CLOCK: BMAL1 function leading to altered circadian gene expression. PLoS One, 6, 2011, e23982.
2. Duncan, W.C., Sarasso, S., Ferrarelli, F., Selter, J., Riedner, B.A., Hejazi, N.S., et al. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int J Neuropsychopharmacol 16 (2013), 301–311.
3. Duncan, W.C. Jr., Selter, J., Brutsche, N., Sarasso, S., Zarate, C.A. Jr., Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder. J Affect Disord 145 (2013), 115–119.
4. Duncan, W.C. Jr., Zarate, C.A. Jr., Ketamine, sleep, and depression: current status and new questions. Curr Psychiatry Rep, 15, 2013, 394.
5. Archer, S.N., Laing, E.E., Moller-Levet, C.S., van der Veen, D.R., Bucca, G., Lazar, A.S., et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci U S A 111 (2014), E682–E691.
6. Li, N., Lee, B., Liu, R.J., Banasr, M., Dwyer, J.M., Iwata, M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 (2010), 959–964.
7. Duman, R.S., Aghajanian, G.K., Synaptic dysfunction in depression: potential therapeutic targets. Science 338 (2012), 68–72.
8. Maeng, S., Zarate, C.A. Jr., The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9 (2007), 467–474.
9. Machado-Vieira, R., Ibrahim, L., Henter, I.D., Zarate, C.A. Jr., Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol Biochem Behav 100 (2012), 678–687.
10. Teicher, M.H., Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry 3 (1995), 18–35.
11. Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., Pollak, C.P., The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26 (2003), 342–392.
12. Winkler, D., Pjrek, E., Praschak-Rieder, N., Willeit, M., Pezawas, L., Konstantinidis, A., et al. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry 58 (2005), 331–336.
13. Kupfer, D.J., Weiss, B.L., Foster, G., Detre, T.P., Delgado, J., McPartland, R., Psychomotor activity in affective states. Arch Gen Psychiatry 30 (1974), 765–768.
14. Wehr, T.A., Muscettola, G., Goodwin, F.K., Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects. Arch Gen Psychiatry 37 (1980), 257–263.
15. Wolff, Ed, Putnam, F.W., Post, R.M., Motor activity and affective illness. The relationship of amplitude and temporal distribution to changes in affective state. Arch Gen Psychiatry 42 (1985), 288–294.
16. Volkers, A.C., Tulen, J.H., van den Broek, W.W., Bruijn, J.A., Passchier, J., Pepplinkhuizen, L., Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Disord 76 (2003), 23–30.
17. Jones, S.H., Hare, D.J., Evershed, K., Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord 7 (2005), 176–186.
18. Harvey, A.G., Schmidt, D.A., Scarna, A., Semler, C.N., Goodwin, G.M., Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 162 (2005), 50–57.
19. Ankers, D., Jones, S.H., Objective assessment of circadian activity and sleep patterns in individuals at behavioural risk of hypomania. J Clin Psychol 65 (2009), 1071–1086.
20. Gonzalez, R., Tamminga, C.A., Tohen, M., Suppes, T., The relationship between affective state and the rhythmicity of activity in bipolar disorder. J Clin Psychiatry 75 (2014), e317–e322.
21. Reid, K.J., Jaksa, A.A., Eisengart, J.B., Baron, K.G., Lu, B., Kane, P., et al. Systematic evaluation of Axis-I DSM diagnoses in delayed sleep phase disorder and evening-type circadian preference. Sleep Med 13 (2012), 1171–1177.
22. Lemke, M.R., Puhl, P., Broderick, A., Motor activity and perception of sleep in depressed patients. J Psychiatr Res 33 (1999), 215–224.
23. Lemke, M.R., Broderick, A., Zeitelberger, M., Hartmann, W., Motor activity and daily variation of symptom intensity in depressed patients. Neuropsychobiology 36 (1997), 57–61.
24. Burton, C., McKinstry, B., Szentagotai Tatar, A., Serrano-Blanco, A., Pagliari, C., Wolters, M., Activity monitoring in patients with depression: A systematic review. J Affect Disord 145 (2013), 21–28.
25. Robillard, R., Naismith, S.L., Smith, K.L., Rogers, N.L., White, D., Terpening, Z., et al. Sleep-wake cycle in young and older persons with a lifetime history of mood disorders. PLoS One, 9, 2014, e87763.
26. Hasler, B.P., Buysse, D.J., Kupfer, D.J., Germain, A., Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression. Psychiatry Res 178 (2010), 205–207.
27. Emens, J., Lewy, A., Kinzie, J.M., Arntz, D., Rough, J., Circadian misalignment in major depressive disorder. Psychiatry Res 168 (2009), 259–261.
28. Benedetti, F., Dallaspezia, S., Fulgosi, M.C., Barbini, B., Colombo, C., Smeraldi, E., Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol Int 24 (2007), 921–937.
29. Kasper, S., Hajak, G., Wulff, K., Hoogendijk, W.J., Montejo, A.L., Smeraldi, E., et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 71 (2010), 109–120.
30. Todder, D., Caliskan, S., Baune, B.T., Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression. World J Biol Psychiatry 10 (2009), 276–284.
31. Todder, D., Caliskan, S., Baune, B.T., Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. J Clin Psychopharmacol 26 (2006), 638–642.
32. Raoux, N., Benoit, O., Dantchev, N., Denise, P., Franc, B., Allilaire, J., et al. Circadian pattern of motor activity in major depressed patients undergoing antidepressant therapy: relationship between actigraphic measures and clinical course. Psychiatry Res 52 (1994), 85–98.
33. McClung, C.A., Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 114 (2007), 222–232.
34. Partonen, T., Clock gene variants in mood and anxiety disorders. J Neural Transm 119 (2012), 1133–1145.
35. Roybal, K., Theobold, D., Graham, A., DiNieri, J., Russo, S.J., Krishnan, V., et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 104 (2007), 6406–6411.
36. McClung, C.A., Circadian rhythms and mood regulation: insights from pre-clinical models. Eur Neuropsychopharmacol 21 Suppl 4 (2011), S683–S693.
37. Hampp, G., Albrecht, U., The circadian clock and mood-related behavior. Commun Integr Biol 1 (2008), 1–3.
38. Hampp, G., Ripperger, J.A., Houben, T., Schmutz, I., Blex, C., Perreau-Lenz, S., et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 18 (2008), 678–683.
39. Schnell, A., Albrecht, U., Sandrelli, F., Rhythm and mood: relationships between the circadian clock and mood-related behavior. Behav Neurosci 128 (2014), 326–343.
40. Milhiet, V., Etain, B., Boudebesse, C., Bellivier, F., Circadian biomarkers, circadian genes and bipolar disorders. J Physiol Paris 105 (2011), 183–189.
41. Harvey, A.G., Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 165 (2008), 820–829.
42. Benedetti, F., Dallaspezia, S., Fulgosi, M.C., Lorenzi, C., Serretti, A., Barbini, B., et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 144B (2007), 631–635.
43. Franken, P., Dijk, D.J., Circadian clock genes and sleep homeostasis. Eur J Neurosci 29 (2009), 1820–1829.
44. Franken, P., A role for clock genes in sleep homeostasis. Curr Opin Neurobiol 23 (2013), 864–872.
45. Franken, P., Thomason, R., Heller, H.C., O'Hara, B.F., A non-circadian role for clock-genes in sleep homeostasis: a strain comparison. BMC Neurosci, 8, 2007, 87.
46. Moller-Levet, C.S., Archer, S.N., Bucca, G., Laing, E.E., Slak, A., Kabiljo, R., et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A 110 (2013), E1132–E1141.
47. Ibrahim, L., Diazgranados, N., Franco-Chaves, J., Brutsche, N., Henter, I.D., Kronstein, P., et al. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology 37 (2012), 1526–1533.
48. Ionescu, D.F., Luckenbaugh, D.A., Niciu, M.J., Richards, E.M., Zarate, C.A.J., A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord 17 (2015), 438–443.
49. Sackeim, H.A., The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 Suppl 16 (2001), 10–17.
50. Zarate, C.A. Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (2006), 856–864.
51. Erzberger, A., Hampp, G., Granada, A.E., Albrecht, U., Herzel, H., Genetic redundancy strengthens the circadian clock leading to a narrow entrainment range. J R Soc Interface, 10, 2013, 20130221.
52. Boivin, D.B., Czeisler, C.A., Dijk, D.J., Duffy, J.F., Folkard, S., Minors, D.S., et al. Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry 54 (1997), 145–152.
53. Wirz-Justice, A., Diurnal variation of depressive symptoms. Dialogues Clin Neurosci 10 (2008), 337–343.
54. Naismith, S.L., Lagopoulos, J., Hermens, D.F., White, D., Duffy, S.L., Robillard, R., et al. Delayed circadian phase is linked to glutamatergic functions in young people with affective disorders: A proton magnetic resonance spectroscopy study. BMC Psychiatry, 14, 2014, 345.
55. Allebrandt, K.V., Teder-Laving, M., Akyol, M., Pichler, I., Muller-Myhsok, B., Pramstaller, P., et al. CLOCK gene variants associate with sleep duration in two independent populations. Biol Psychiatry 67 (2010), 1040–1047.
56. Novakova, M., Sladek, M., Sumova, A., Human chronotype is determined in bodily cells under real-life conditions. Chronobiol Int 30 (2013), 607–617.
57. Baehr, E.K., Revelle, W., Eastman, C.I., Individual differences in the phase and amplitude of the human circadian temperature rhythm: with an emphasis on morningness-eveningness. J Sleep Res 9 (2000), 117–127.
58. Haile, C.N., Murrough, J.W., Iosifescu, D.V., Chang, L.C., Al Jurdi, R.K., Foulkes, A., et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 17 (2014), 331–336.
59. Bunney, B.G., Li, J.Z., Walsh, D.M., Stein, R., Vawter, M.P., Cartagena, P., et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry 20 (2015), 48–55.
60. Cao, R., Lee, B., Cho, H.Y., Saklayen, S., Obrietan, K., Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock. Mol Cell Neurosci 38 (2008), 312–324.
61. Cao, R., Li, A., Cho, H.Y., Lee, B., Obrietan, K., Mammalian target of rapamycin signaling modulates photic entrainment of the suprachiasmatic circadian clock. J Neurosci 30 (2010), 6302–6314.
62. Zarate, C.A. Jr., Brutsche, N., Laje, G., Luckenbaugh, D.A., Venkata, S.L., Ramamoorthy, A., et al. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry 72 (2012), 331–338.
63. Zanos, P., Moaddel, R., Morris, P.J., Georgiou, P., Fischell, J., Elmer, G.I., et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533 (2016), 481–486.
64. Li, J.Z., Bunney, B.G., Meng, F., Hagenauer, M.H., Walsh, D.M., Vawter, M.P., et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A 110 (2013), 9950–9955.
65. Mukherjee, S., Coque, L., Cao, J.L., Kumar, J., Chakravarty, S., Asaithamby, A., et al. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 68 (2010), 503–511.
66. Tan, S., Lam, W.P., Wai, M.S., Yu, W.H., Yew, D.T., Chronic ketamine administration modulates midbrain dopamine system in mice. PLoS One, 7, 2012, e43947.
67. van Someren, E.J., Swaab, D.F., Colenda, C.C., Cohen, W., McCall, W.V., Rosenquist, P.B., Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chroniobiol Int 16 (1999), 505–518.
68. Wirz-Justice, A., How to measure circadian rhythms in humans. Medicographia 29 (2007), 84–90.